A Single Amino Acid Residue on the α5 Subunit (Ile215) Is Essential for Ligand Selectivity at α5β3γ2 γ-Aminobutyric AcidA Receptors

Imidazobenzodiazepines such as RY-80 have been reported to exhibit both high affinity and selectivity for GABAA receptors containing an α5 subunit. A single amino acid residue (α5Ile215) has been identified that plays a critical role in the high-affinity, subtype-selective effects of RY-80 and structurally related ligands. Thus, substitution of α5Ile215 with the cognate amino acid contained in the α1 subunit (Val211) reduced the selectivity of RY-80 for α5β3γ2 receptors from ∼135- to ∼8-fold compared with α1β3γ2 receptors. This mutation produced a comparable reduction in the selectivity of RY-24 (a structural analog of RY-80) for α5β3γ2 receptors but did not markedly alter the affinities of ligands (e.g., flunitrazepam) that are not subtype-selective. Conversely, substitution of the α1subunit with the cognate amino acid contained in the α5subunit (i.e., α1V211I) increased the affinities of α5-selective ligands by a ∼20-fold and reduced by 3-fold the affinity of an α1-selective agonist (zolpidem). Increasing the lipophilicity (e.g., by substitution of Phe) of α5215 did not significantly affect the affinities (and selectivities) of RY-80 and RY-24 for α5-containing GABAA receptors. However, the effect of introducing hydrophilic and or charged residues (e.g., Lys, Asp, Thr) at this position was no greater than that produced by the α5I215V mutation. These data indicate that residue α5215 may not participate in formation of the lipophilic L2 pocket that has been proposed to contribute to the unique pharmacological properties of α5-containing GABAA receptors. RY-80 and RY-24 acted as inverse agonists in both wild-type α5β3γ2 and mutant α5I215Kβ3γ2 receptors expressed in Xenopus laevis oocytes. However, both RY-24 and RY-80 acted as antagonists at mutant α5I215Vβ3γ2 and α5I215Tβ3γ2 receptors, whereas the efficacy of flunitrazepam was similar at all three receptor isoforms. The data demonstrate that amino acid residue α5215 is a determinant of both ligand affinity and efficacy at GABAA receptors containing an α5subunit.

[1]  R. Mckernan,et al.  theta, a novel gamma-aminobutyric acid type A receptor subunit. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[2]  R. Mckernan,et al.  Autoradiographic localization of α5 subunit-containing GABAA receptors in rat brain , 1999, Brain Research.

[3]  R. Dingledine,et al.  The glutamate receptor ion channels. , 1999, Pharmacological reviews.

[4]  Deborah Dewar,et al.  Rat and Human Hippocampal α5 Subunit-Containing γ-Aminobutyric AcidA Receptors Have α5β3γ2 Pharmacological Characteristics , 1998 .

[5]  J. Benson,et al.  Pharmacology of recombinant γ‐aminobutyric acidA receptors rendered diazepam‐insensitive by point‐mutated α‐subunits , 1998 .

[6]  C. Czajkowski,et al.  Molecular dissection of benzodiazepine binding and allosteric coupling using chimeric gamma-aminobutyric acidA receptor subunits. , 1998, Molecular pharmacology.

[7]  P. Skolnick,et al.  [3H]RY 80: A high-affinity, selective ligand for gamma-aminobutyric acidA receptors containing alpha-5 subunits. , 1997, The Journal of pharmacology and experimental therapeutics.

[8]  E. Sigel,et al.  The benzodiazepine binding site of GABAA receptors. , 1997, Trends in pharmacological sciences.

[9]  W. Wisden,et al.  GABA(A)-receptor subtypes: clinical efficacy and selectivity of benzodiazepine site ligands. , 1997, Annals of medicine.

[10]  Werner Sieghart,et al.  Stoichiometry and Assembly of a Recombinant GABAA Receptor Subtype , 1997, The Journal of Neuroscience.

[11]  P. Skolnick,et al.  Pharmacological Properties of Recombinant “Diazepam-insensitive” GABAA Receptors , 1996, Neuropharmacology.

[12]  P. Leeson,et al.  [3H]L-655,708, a Novel Ligand Selective for the Benzodiazepine Site of GABAA Receptors which Contain the α5 Subunit , 1996, Neuropharmacology.

[13]  D. S. Weiss,et al.  Stoichiometry of a Recombinant GABAA Receptor , 1996, The Journal of Neuroscience.

[14]  F. Besnard,et al.  Pharmacological profile of benzodiazepine site ligands with recombinant GABAA receptor subtypes , 1996, European Neuropsychopharmacology.

[15]  P. Skolnick,et al.  Synthesis and pharmacological properties of novel 8-substituted imidazobenzodiazepines: high-affinity, selective probes for alpha 5-containing GABAA receptors. , 1996, Journal of medicinal chemistry.

[16]  R. Mckernan,et al.  Which GABAA-receptor subtypes really occur in the brain? , 1996, Trends in Neurosciences.

[17]  J. Fritschy,et al.  GABAA‐receptor heterogeneity in the adult rat brain: Differential regional and cellular distribution of seven major subunits , 1995, The Journal of comparative neurology.

[18]  P. Seeburg,et al.  GABAA/Benzodiazepine receptor heterogeneity: Neurophysiological implications , 1995, Neuropharmacology.

[19]  H. Wieland,et al.  Four amino acid exchanges convert a diazepam-insensitive, inverse agonist-preferring GABAA receptor into a diazepam-preferring GABAA receptor. , 1994, Journal of medicinal chemistry.

[20]  P. Seeburg,et al.  Impact of beta and gamma variants on ligand-binding properties of gamma-aminobutyric acid type A receptors. , 1994, Molecular pharmacology.

[21]  N. Nayeem,et al.  Quaternary Structure of the Native GABAA Receptor Determined by Electron Microscopic Image Analysis , 1994, Journal of neurochemistry.

[22]  P. Whiting,et al.  Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors. , 1993, Molecular pharmacology.

[23]  P. Skolnick,et al.  Stable expression of type I gamma-aminobutyric acidA/benzodiazepine receptors in a transfected cell line. , 1992, Molecular pharmacology.

[24]  E. Korpi,et al.  Substrate specificity of diazepam-insensitive cerebellar [3H]Ro 15-4513 binding sites. , 1992, European journal of pharmacology.

[25]  P. Seeburg,et al.  A single histidine in GABAA receptors is essential for benzodiazepine agonist binding. , 1992, The Journal of biological chemistry.

[26]  E. Sigel,et al.  The γ3‐subunit of the GABAA‐receptor confers sensitivity to benzodiazepine receptor ligands , 1991 .

[27]  E. Costa,et al.  Influence of recombinant gamma-aminobutyric acid-A receptor subunit composition on the action of allosteric modulators of gamma-aminobutyric acid-gated Cl- currents. , 1991, Molecular pharmacology.

[28]  P. Seeburg,et al.  γ‐Aminobutyric AcidA Receptor α5‐Subunit Creates Novel Type II Benzodiazepine Receptor Pharmacology , 1990 .

[29]  P. Seeburg,et al.  Importance of a novel GABAA receptor subunit for benzodiazepine pharmacology , 1989, Nature.

[30]  C. Braestrup,et al.  Some properties of brain specific benzodiazepine receptors: New evidence for multiple receptors , 1979, Pharmacology Biochemistry and Behavior.

[31]  T. Okada,et al.  Biochemical identification of the site of action of benzodiazepines in human brain by 3H-diazepam binding. , 1978, Life sciences.

[32]  C. Gorman,et al.  Transient production of proteins using an adenovirus transformed cell line , 1990 .